Symptoms and General Pathology

All Conditions

Mobility Limitation

Standard treatment and mobilization recommendations will be given to this group.

Mobilization of patients will be encouraged.

Standard mobilization recommendations will be given to all patients, and feedback will be given to the intervention group to increase the number of steps 4 times a day according to the daily targeted number of steps.

Mobilization recommendations

Kamil Erozkan, Fellow

Ali Ekrem Unal, Professor

Ali Ekrem Unal, MD

The clinical progress of the patients whose mobilization the investigators follow up with wearable technology products will be observed in the early postoperative period until discharge. In this way, the investigators primarily aim to examine whether the bowel movements of our more mobilized patients return earlier.

Can Wearable Technology Products Change Our Patient Management in Laparoscopic Colorectal Cancer Surgery

If requested, individual participant data (IPD) will be shared via e-mail after the reason has been evaluated.

Ankara University

Clinical Fellow

Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Prostatic Neoplasms

Analgesics

Central Nervous System Depressants

All Drugs and Chemicals

Narcotics

This group will be given a pedometer following radical prostatectomy. Subjects in the experimental group will have a graduated step-count goal as follows: POD 0-2: 2,000/day. POD 3-6: 3,000/day. POD 7-9: 4,000/day. POD 10-14: 5,000/day.

This is the control group. Following radical prostatectomy, subjects in the control group will receive standard of care, which includes counseling regarding the importance of ambulation following surgery.

Subjects in the study group will receive a pedometer with graduated step count goals as discussed in arm description.

Use of a pedometer following surgery

Subjects in the control group will be counseled on the importance of ambulation during their pre-operative visit.

Standard of care

Basil Ferenczi, MD

John Corman, MD

This is a study to evaluate whether use of a pedometer following radical prostatectomy decreases post-operative narcotic use and time to return of bowel function.

This is a randomized controlled prospective study looking at the effect of using a pedometer with graduated step-count goals following radical prostatectomy on return of bowel function and post-operative narcotic use. Subjects will be randomized into a control group or study group. The control group will receive standard of care, with information provided regarding the importance of ambulation following surgery. The study group will receive a pedometer with graduated step-count goals from post-operative day 0 to post-operative day 14. Both groups will be given a standardized post-operative narcotic regimen, and will be asked to record initial passage of flatus and first bowel movement. Subjects will remain on the study until initial post-operative visit.

Use of Pedometer Following Radical Prostatectomy

Does the Use of a Post-Operative Pedometer Affect Rate of Return of Bowel Function and Narcotic Use Following Laparoscopic Robot Assisted Radical Prostatectomy

Morphine equivalents used following radical prostatectomy.

First passage of flatus and first bowel movement following surgery

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Can Wearable Technology Products Change Our Patient Management in Laparoscopic Colorectal Cancer Surgery	NCT05598294	Ambulation Diff... Physical Examin...	Mobilization re...	18 Years -	Ankara University
Can Wearable Technology Products Change Our Patient Management in Laparoscopic Colorectal Cancer Surgery	NCT05598294	Ambulation Diff... Physical Examin...	Mobilization re...	18 Years -	Ankara University
Use of Pedometer Following Radical Prostatectomy	NCT04206280	Prostate Cancer Ambulation Diff...	Use of a pedome... Standard of car...	18 Years - 75 Years	Benaroya Research Institute
Use of Pedometer Following Radical Prostatectomy	NCT04206280	Prostate Cancer Ambulation Diff...	Use of a pedome... Standard of car...	18 Years - 75 Years	Benaroya Research Institute

Spots Global Cancer Trial Database for ambulation difficulty